1. Loss of exosomal miR-148b from cancer-associated fibroblasts promotes endometrial cancer cell invasion and cancer metastasis
   Bi-Lan Li et al, 2018, J Cell Physiol CrossRef
2. Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer
   Rongsheng Zhang et al, 2019, Cell Death Dis CrossRef
3. The influence of microenvironment on tumor immunotherapy.
   Jieying Zhang et al, 2019, FEBS J CrossRef
4. Crosstalk between cancer‐associated fibroblasts and immune cells in cancer
   Yuanyuan An et al, 2019, J Cell Mol Med CrossRef
5. Targeting Natural Killer Cells for Tumor Immunotherapy.
   Cai Zhang et al, 2020, Front Immunol CrossRef
6. The tumor microenvironment and radiotherapy response; a central role for cancer-associated fibroblasts
   Marleen Ansems et al, 2020, Clinical and Translational Radiation Oncology CrossRef
7. Characterization of lncRNA-Associated ceRNA Network to Reveal Potential Prognostic Biomarkers in Lung Adenocarcinoma
   Yang Wang et al, 2020, Front. Bioeng. Biotechnol. CrossRef
8. Melanoma-associated fibroblasts impair CD8+ T cell function and modify expression of immune checkpoint regulators via increased arginase activity
   Barbara Érsek et al, 2020, Cell. Mol. Life Sci. CrossRef
9. Cancer-associated fibroblasts: key determinants of tumor immunity and immunotherapy
   Richard Barrett et al, 2020, Current Opinion in Immunology CrossRef
10. Extracellular vesicle encapsulated microRNA-320a inhibits endometrial cancer by suppression of the HIF1α/VEGFA axis
    Na Zhang et al, 2020, Experimental Cell Research CrossRef
11. Functional and metabolic targeting of natural killer cells to solid tumors.
    Jiao Wang et al, 2020, Cell Oncol (Dordr) CrossRef
12. Natural killer cells in cancer biology and therapy
    Song-Yang Wu et al, 2020, Mol Cancer CrossRef
13. Cancer-associated fibroblasts in therapeutic resistance of pancreatic cancer: Present situation, predicaments, and perspectives
    Xuan Han et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
14. Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies
    Rana Mhaidly et al, 2020, Seminars in Immunology CrossRef
15. Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy
    Richard Lee Barrett et al, 2020 CrossRef
16. Single-Cell RNA-Seq Reveals Dynamic Change in Tumor Microenvironment During Pancreatic Ductal Adenocarcinoma Malignant Progression
    Kai Chen et al, 2020, SSRN Journal CrossRef
17. Radiotherapy: An immune response modifier for immuno-oncology
    Mara De Martino et al, 2021, Seminars in Immunology CrossRef
18. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression
    Kai Chen et al, 2021, EBioMedicine CrossRef
19. Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime
    De Pradip et al, 2021, IJMS CrossRef
20. Targeting cancer-associated fibroblasts in immunotherapy
    Dongyoon Kim et al, 2022 CrossRef
21. Biology of NK Cells and NK Cells in Clinic
    Grace C. Birch et al, 2022 CrossRef
22. Targeting CAFs to overcome anticancer therapeutic resistance
    Phei Er Saw et al, 2022, Trends in Cancer CrossRef
23. Defining the molecular landscape of cancer-associated stroma in cutaneous squamous cell carcinoma
    Erin Beebe et al, 2022, Journal of Investigative Dermatology CrossRef
24. Fight the Cancer, Hit the CAF!
    Andrea Papait et al, 2022, Cancers CrossRef
25. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment
    Yifei Zhu et al, 2022, Front. Endocrinol. CrossRef
26. Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting.
    Rahul Rimal et al, 2022, Adv Drug Deliv Rev CrossRef
27. Functional crosstalk and regulation of natural killer cells in tumor microenvironment: Significance and potential therapeutic strategies
    Liping Wang et al, 2022, Genes & Diseases CrossRef
28. Understanding the functional inflammatory factors involved in therapeutic response to immune checkpoint inhibitors for pan-cancer
    Yanmeizhi Wu et al, 2022, Front. Pharmacol. CrossRef
29. Modulation of the antitumor immune response by cancer-associated fibroblasts: mechanisms and targeting strategies to hamper their immunosuppressive functions
    Jerome Thiery, 2022 CrossRef
30. NK cells and solid tumors: therapeutic potential and persisting obstacles
    Le Tong et al, 2022, Mol Cancer CrossRef
31. Chasing Uterine Cancer with NK Cell-Based Immunotherapies
    Vijay Kumar et al, 2022, Future Pharmacology CrossRef
32. Reversing the NK inhibitory tumor microenvironment by targeting suppressive immune effectors
    Ishwar Navin et al, 2023 CrossRef
33. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Xiaoqi Mao et al, 2021, Mol Cancer CrossRef
34. NK cells are never alone: crosstalk and communication in tumour microenvironments.
    Yongqiang Zhou et al, 2023, Mol Cancer CrossRef
35. Immune Checkpoint Inhibitors in HBV-Caused Hepatocellular Carcinoma Therapy
    Jin Zhang et al, 2023, Vaccines CrossRef
36. Cancer-associated fibroblasts in gynecological malignancies: are they really allies of the enemy?
    Julio César Villegas-Pineda et al, 2023, Front. Oncol. CrossRef
37. Natural killer cell epigenetic reprogramming in tumors and potential for cancer immunotherapy
    Tahereh Hojjatipour et al, 2023, Epigenomics CrossRef
38. Construction of a prognostic signature of RFC5 immune-related genes in patients with cervical cancer
    Huaqiu Chen et al, 2023, CBM CrossRef
39. Clinical significance of CD155 expression and correlation with cellular components of tumor microenvironment in gastric adenocarcinoma
    Xue Liu et al, 2023, Front. Immunol. CrossRef
40. Cancer-associated fibroblasts: Just on the opposite side of antitumour immunity?
    Shuaiqingying Guo et al, 2023, International Immunopharmacology CrossRef
41. Suppression of the antitumoral activity of natural killer cells under indirect coculture with cancer-associated fibroblasts in a pancreatic TIME-on-chip model
    Hyun-Ah Kim et al, 2023, Cancer Cell Int CrossRef
42. The cellular triumvirate: fibroblasts entangled in the crosstalk between cancer cells and immune cells
    Adel Fergatova et al, 2024, Front. Immunol. CrossRef
43. Cancer-associated fibroblasts: heterogeneity and their role in the tumor immune response.
    Yuxuan Xiao et al, 2024, Clin Exp Med CrossRef
44. Pexidartinib and Immune Checkpoint Inhibitors Combine to Activate Tumor Immunity in a Murine Colorectal Cancer Model by Depleting M2 Macrophages Differentiated by Cancer-Associated Fibroblasts
    Daisuke Shimizu et al, 2024, IJMS CrossRef
45. The Nectin family ligands, PVRL2 and PVR, in cancer immunology and immunotherapy
    Kosuke Murakami et al, 2024, Front. Immunol. CrossRef
46. Exosomal CTHRC1 from cancer-associated fibroblasts facilitates endometrial cancer progression via ITGB3/FAK signaling pathway
    Yiding Bian et al, 2024, Heliyon CrossRef
47. Drug resistance and tumor immune microenvironment: An overview of current understandings (Review)
    Yan Liu et al, 2024, Int J Oncol CrossRef
48. From darkness to light: Targeting CAFs as a new potential strategy for cancer treatment
    Haixia Tian et al, 2024, International Immunopharmacology CrossRef